Trial · NCT07890818
Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring
NCT07890818, Not applicable, Not yet recruiting, University of Cincinnati
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring. Trials, record NCT07890818. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890818
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring
- NCT number
- NCT07890818
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 218 participants, estimated
- Lead sponsor
- University of Cincinnati
- Conditions
- Type 2 Diabetes
- Interventions
- Continuous glucose monitor
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Glycemic control as measured by Hemoglobin A1c (HbA1c) | From enrollment to end of monitoring at 12 weeks | A reduction in Hemoglobin A1C is being studied. With the current sample size, we expect a reduction in Hemoglobin A1C level by 0.5 as compared to the POC glucose monitoring arm to be significant after 12 weeks. |
| Secondary | Hospital readmissions over 12 weeks | 12 weeks | Any cause readmission to the hospital in the 12 weeks after enrollment will be measured |
| Secondary | Diabetes related readmissions at 12 weeks | 12 weeks | A diabetes related readmission to the hospital in the 12 weeks after enrollment will be measured |
| Secondary | Hypoglycemic events as measured by low glucose reading and symptoms as described by patients at follow up | 12 weeks | Hypoglycemic events as measured by low glucose reading and symptoms as described by patients at follow up within 12 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 39694328 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890818
GET https://conductscience.org/api/trials/v1/NCT07890818/registered